Breast

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(CCTG) MA.39 / TAILOR RTA randomized trial of regional radiotherapy in Biomarker low risk node positive breast cancer (TAILOR RT)Whelan, Dr TimothyOpen to recruitmentNCT03488693
(CCTG) MAC.20/Alliance A011401/BWEL studyRandomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast CancerBordeleau, Dr LouiseOpen to recruitmentNCT02750826
(CCTG) MAC.23 / Alliance A221505 / RT CHARMPhase III Randomized Trial of Hypofractionated Post-Mastectomy Radiation with Breast ReconstructionKong, Dr IwaOpen to recruitmentNCT03414970
(HHS) SBRT Breast / STOMPStereotactic Body Radiotherapy (SBRT) for the Treatment of OligoMetastasis in Breast Cancer Patients (STOMP): A Prospective Feasibility TrialSwaminath, Dr AnandOpen to recruitmentNCT03295916
(Roche) CO41012 / IPATunity150A PHASE IB/III STUDY OF IPATASERTIB PLUS PALBOCICLIB AND FULVESTRANT VERSUS PLACEBO PLUS PALBOCICLIB AND FULVESTRANT IN HORMONE RECEPTOR POSITIVE AND HER2 NEGATIVE LOCALLY ADVANCED UNRESECTABLE OR METASTATIC BREAST CANCERMukherjee, Dr SomOpen to recruitmentNCT04060862
OCOG-2016-PETABCImpact of 18F-FDG PET-CT versus Conventional Staging in the Management of Patients Presenting with Clinical Stage III Breast Cancer Dhesy, Dr BindiOpen to recruitmentNCT02751710
OCOG-2019-RHEALRandomized Trial of Hypofractionated LocoRegional Radiotherapy in Breast Cancer and Lymphedema (RHEAL)Goldberg, Dr MiraOpen to recruitmentNCT04228991
(CCTG) MAC.24 / S1418 / BR006 / MK-3475-242A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant ChemotherapyKumar-Tyagi, Dr NidhiSuspended/On holdNCT02954874
Download PDF